Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 5, 2018
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects
Tan Zhang, Guihong Chen, Chang Liu, et al.
Frontiers in Plant Science
|
May 18, 2021
Diverged Early From CtpB and CtpC, CtpA Has Evolved to Process D1 Precursor in Oxygenic Photosynthetic Organisms
Weidong Chang, Chenggang Li, Zheng Cui, et al.
Expert Opinion on Investigational Drugs
|
February 9, 2023
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
Diqin Yan, Suping Niu, Dingyuan Hu, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 26, 2025
Endophilin B1 is essential for maintaining cardiac function by regulating mitocytosis
Jingyu Deng, Xiaoqian Chang, Xiaomeng Zhang, et al.
European Journal of Clinical Pharmacology
|
June 23, 2017
Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers
Yitong Wang, Chang Liu, Shi Chen, et al.
The Plant Journal : for Cell and Molecular Biology
|
September 29, 2021
Structural variation of mitochondrial genomes sheds light on evolutionary history of soybeans
Hao Liu, Junping Yu, Xiaoxia Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2020
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Bixia Tang, Zhihong Chi, Yingbo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2020
Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Bixia Tang, Zhihong Chi, Yingbo Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2020
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
Jianliang Yang, Lihou Dong, Sheng Yang, et al.
BMC Cancer
|
December 23, 2017
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge, Ruilei Li, Haifeng Song, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 5, 2018
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects
Tan Zhang, Guihong Chen, Chang Liu, et al.
Frontiers in Plant Science
|
May 18, 2021
Diverged Early From CtpB and CtpC, CtpA Has Evolved to Process D1 Precursor in Oxygenic Photosynthetic Organisms
Weidong Chang, Chenggang Li, Zheng Cui, et al.
Expert Opinion on Investigational Drugs
|
February 9, 2023
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
Diqin Yan, Suping Niu, Dingyuan Hu, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 26, 2025
Endophilin B1 is essential for maintaining cardiac function by regulating mitocytosis
Jingyu Deng, Xiaoqian Chang, Xiaomeng Zhang, et al.
European Journal of Clinical Pharmacology
|
June 23, 2017
Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers
Yitong Wang, Chang Liu, Shi Chen, et al.
The Plant Journal : for Cell and Molecular Biology
|
September 29, 2021
Structural variation of mitochondrial genomes sheds light on evolutionary history of soybeans
Hao Liu, Junping Yu, Xiaoxia Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2020
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Bixia Tang, Zhihong Chi, Yingbo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2020
Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Bixia Tang, Zhihong Chi, Yingbo Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2020
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
Jianliang Yang, Lihou Dong, Sheng Yang, et al.
BMC Cancer
|
December 23, 2017
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Chunlei Ge, Ruilei Li, Haifeng Song, et al.
Page
of 16